High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial (Q44483991)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial |
scientific article |
Statements
1 reference
High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial (English)
1 reference
J Sanford Schwartz
1 reference
Y Richard Wang
1 reference
John G F Cleland
1 reference
Longlong Gao
1 reference
Mark Weiner
1 reference
Philip A Poole-Wilson
1 reference
ATLAS Study Group
1 reference
1 June 2003
1 reference
1 reference
9
1 reference
6
1 reference
417-424
1 reference
Identifiers
1 reference